The cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice
Philippe Gallay(Scripps Research Institute), Robert T. Foster(Edison Pharmaceuticals (United States))
Cited by 41
Related Papers
Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells
|The Open Virology Journal|2014|9